EZZ Life Science Holdings Limited

ASX:EZZ.AX

2.46 (AUD) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2025 Q22024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q2
Revenue 30.28844.74721.69722.01815.1268.8086.2149.72312.5658.2489.0675.5945.594
Cost of Revenue 6.97910.0137.145.3364.6054.8293.6995.0095.6276.4447.313.4133.413
Gross Profit 23.30934.73414.55716.68210.5213.9792.5154.7136.9381.8041.7582.182.18
Gross Profit Ratio 0.770.7760.6710.7580.6960.4520.4050.4850.5520.2190.1940.390.39
Reseach & Development Expenses 0000000000000
General & Administrative Expenses 1.2050.1170.0590.0490.0710.060.0790.0680.010.0740.0740.450.45
Selling & Marketing Expenses 16.31725.4965.8676.3993.880.8640.6211.5852.3370.2730.5040.9850.985
SG&A 17.52226.51113.06413.828.7672.3482.5043.6885.390.8621.221.5921.592
Other Expenses 0000000000000
Operating Expenses 17.52226.51113.06413.828.7672.3482.5043.6885.390.8621.221.5921.592
Operating Income 5.7878.2231.4932.8621.7541.6310.0111.0251.5480.9430.5370.5890.589
Operating Income Ratio 0.1910.1840.0690.130.1160.1850.0020.1050.1230.1140.0590.1050.105
Total Other Income Expenses Net -1.0280.210.0330.2610.0250.0330.1040.030.1340.674-0.00400
Income Before Tax 4.7598.4331.5263.1221.7781.6640.1161.0551.6821.6170.5330.5890.589
Income Before Tax Ratio 0.1570.1880.070.1420.1180.1890.0190.1080.1340.1960.0590.1050.105
Income Tax Expense 1.5612.6110.3840.7920.4790.4510.0160.2470.4590.4030.1610.1770.177
Net Income 3.1985.8221.1422.3311.2991.2130.10.8081.2231.2140.3720.4120.412
Net Income Ratio 0.1060.130.0530.1060.0860.1380.0160.0830.0970.1470.0410.0740.074
EPS 0.0710.130.0270.0550.030.0290.0020.0190.0290.0290.0090.010.01
EPS Diluted 0.0710.130.0270.0550.030.0290.0020.0190.0290.0290.0090.010.01
EBITDA 4.8068.6441.7323.2541.8391.7260.1761.1241.751.0160.6110.590.59
EBITDA Ratio 0.1590.1930.080.1480.1220.1960.0280.1160.1390.1230.0670.1060.106